SCHEMBL26199262

SCHEMBL26199262

Cn1ccc(-c2cc(C#N)cc(-c3ccc(F)cc3)c2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 1/20 0.52
CYP19A1 P11511 2/20 0.44
KEAP1 Q14145 1/20 0.41
GRM5 P41594 4/20 0.41
PGR P06401 2/20 0.40
KMT2A Q03164 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
CSNK1D P48730 2/20 0.39
CSNK1A1 P48729 1/20 0.39
MAPK14 Q16539 1/20 0.39
BRAF P15056 1/20 0.38
KDR P35968 1/20 0.38
DRD2 P14416 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30510117 0.82 TGFBR1 (0.43) SCN4ACYP19A1GRM5PGRGABRG2
SCHEMBL25375800 0.82 TGFBR1 (0.43) SCN4ACYP19A1GRM5PGRGABRG2
SCHEMBL989300 0.78 SCN4A (0.79) SCN4ACYP19A1KEAP1KMT2AMKNK1
SCHEMBL28037273 0.76 KEAP1 (0.58) SCN4ACYP19A1KEAP1KMT2ACYP11B2
SCHEMBL26199143 0.76 SCN4A (0.48) SCN4AKEAP1PGRKMT2ACSNK1D
SCHEMBL15729287 0.74 KMT2A (0.46) SCN4ACYP19A1KEAP1KMT2AMKNK1
SCHEMBL8807623 0.74 GRM5 (0.58) GRM5KMT2AGABRG2GABRB3GABRA5
SCHEMBL25833010 0.73 SCN4A (0.45) SCN4AKEAP1PGRMKNK1MKNK2
SCHEMBL25830785 0.72 CYP19A1 (0.42) CYP19A1GRM5PGRGABRG2GABRB3
SCHEMBL28067366 0.72 SCN4A (0.56) SCN4ACYP19A1KEAP1KMT2AMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 SCN4A 4415/4885CYP19A1 3086/4885KEAP1 202/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 SCN4A 4415/4885CYP19A1 3086/4885KEAP1 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.